U.S. federal trademark · Serial No. 97381872 · Reg. No. 7036963
Laboratory research in the field of genomics and immuno-oncology, namely, product development in the nature of development of diagnostic molecular testing for analyzing disease and genome information, in particular an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA from cancer cells to detect mutations therein and provide assessment and information about such mutations for the purpose of evaluating and screening patients for clinical trials in planning medical treatment for and providing targeted therapy selection to cancer patients
Medical testing for diagnostic or treatment purposes in the field of cancer and infectious diseases using an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA; Medical testing services relating to the diagnosis and treatment of disease
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.